Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Thomas

Showing results (161-170 of 217) with videos related to

Pageof 22
Sort By:
Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Journal of Medical Genetics|March 18, 2020
Germline <i>RET</i> variants underlie a subset of paediatric osteosarcomaMichal Kovac, Connor Woolley, Sebastian Ribi, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High TumorsDavid M Thomas, Jeong Eun Kim, Fabrice Barlesi, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
BMC Medical Genomics|June 3, 2014
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencingStephen Q Wong, Jason Li, Angela Y-C Tan, et al.
Personalized Medicine|May 2, 2018
A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findingsVictoria Rasmussen, Laura E Forrest, Muriel Rogasik, et al.
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Pageof 22

Showing results (161-170 of 217) with videos related to

Sort By:
Pageof 22
Molecular Oncology|November 25, 2022
Early circulating tumor DNA dynamics as a pan-tumor biomarker for long-term clinical outcome in patients treated with durvalumab and tremelimumabMaya Kansara, Neeru Bhardwaj, Subotheni Thavaneswaran, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 15, 2013
Benefits and adverse events in younger versus older patients receiving neoadjuvant chemotherapy for osteosarcoma: findings from a meta-analysisMarnie Collins, Miriam Wilhelm, Rachel Conyers, et al.
Journal of Medical Genetics|March 18, 2020
Germline <i>RET</i> variants underlie a subset of paediatric osteosarcomaMichal Kovac, Connor Woolley, Sebastian Ribi, et al.
Plos One|October 3, 2013
Next-generation sequence analysis of cancer xenograft modelsFernando J Rossello, Richard W Tothill, Kara Britt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2026
TAPISTRY: A Phase II Study of Atezolizumab in Patients with Tumor Mutational Burden-High TumorsDavid M Thomas, Jeong Eun Kim, Fabrice Barlesi, et al.
JCO Precision Oncology|January 7, 2022
Novel RET Fusion <i>RET-SEPTIN9</i> Predicts Response to Selective RET Inhibition With Selpercatinib in Malignant PheochromocytomaAngela Mweempwa, Huiling Xu, Joseph H A Vissers, et al.
BMC Medical Genomics|June 3, 2014
Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencingStephen Q Wong, Jason Li, Angela Y-C Tan, et al.
Personalized Medicine|May 2, 2018
A comparison of Australian and French families affected by sarcoma: perceptions of genetics and incidental findingsVictoria Rasmussen, Laura E Forrest, Muriel Rogasik, et al.
British Journal of Cancer|June 26, 2023
A signal-seeking Phase 2 study of olaparib and durvalumab in advanced solid cancers with homologous recombination repair gene alterationsSubotheni Thavaneswaran, Maya Kansara, Frank Lin, et al.
Cancer Research|November 14, 2019
Penetrance of Different Cancer Types in Families with Li-Fraumeni Syndrome: A Validation Study Using Multicenter CohortsSeung Jun Shin, Elissa B Dodd-Eaton, Gang Peng, et al.
Pageof 22